| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECTA BIOSCIENCES INC | 1,924,151 | 32,999,000 | 39.17% | ||
| 2 | TREVENA INC | 2,053,540 | 12,075,000 | 14.33% | ||
| 3 | T2 BIOSYSTEMS INC | 1,875,524 | 9,865,000 | 11.71% | ||
| 4 | GENOCEA BIOSCIENCES INC | 1,968,606 | 8,111,000 | 9.63% | ||
| 5 | OCULAR THERAPEUTIX INC | 788,723 | 6,602,000 | 7.84% | ||
| 6 | FATE THERAPEUTICS INC COM | 2,473,186 | 6,208,000 | 7.37% | ||
| 7 | Life Technologies Corp | 1,827,992 | 3,930,000 | 4.66% | ||
| 8 | CERULEAN PHARMA INC | 3,287,529 | 2,328,000 | 2.76% | ||
| 9 | PULMATRIX INC | 3,607,996 | 2,129,000 | 2.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001896, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
